Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03548285 · OUTCOME

Number of Patients With Grade 3-5 Acute and Late Toxicities Following Treatment With SABR

Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer · Source last updated 2025-05-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
90 days, 3 years

What was measured

Number of patients with grade 3-5 acute (start of treatment through 90 days from the completion of treatment) and late (after 90 days from the completion of treatment) adverse events, according to NCI's Common Terminology Criteria for Adverse Events (CTCAE) v4.0 toxicity criteria.

Groups in this outcome

All Patients

All patients on the clinical trial.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients25

Reported measurements

Acute
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients6Not reportedNot reportedNot reportedNot reported
Late
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients19Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        6
    title
    Acute
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        19
    title
    Late
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
description
Number of patients with grade 3-5 acute (start of treatment through 90 days from the completion of treatment) and late (after 90 days from the completion of treatment) adverse events, according to NCI's Common Terminology Criteria for Adverse Events (CTCAE) v4.0 toxicity criteria.
groups
  1. description
    All patients on the clinical trial.
    id
    OG000
    title
    All Patients
param Type
NUMBER
reporting Status
POSTED
time Frame
90 days, 3 years
title
Number of Patients With Grade 3-5 Acute and Late Toxicities Following Treatment With SABR
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice